InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Brannan Stephen K., Directeur Médical. Insider active across 2 companies, notably Karuna Therapeutics, Inc.. Aggregated, 31 disclosures have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €821k. History available since 1 November 2021. The latest transaction was disclosed on 7 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations31 total
1,000 shares@ US$2.03Common StockSEC:0001777631-26-000007:0
Ideal exit: 3 Apr 2027 (T+270)
36,117 shares@ US$330.0083.4% of flowCommon StockSEC:0001140361-24-013922:0
2,500 shares@ US$5.450.1% of flowCommon StockSEC:0000950170-24-029406:0
2,500 shares@ US$5.450.1% of flowCommon StockSEC:0000950170-24-013959:0
2,500 shares@ US$5.450.1% of flowCommon StockSEC:0000950170-24-003372:0
2,500 shares@ US$5.450.1% of flowCommon StockSEC:0000950170-23-069766:0
2,500 shares@ US$5.450.1% of flowCommon StockSEC:0000950170-23-063121:0
2,500 shares@ US$5.450.1% of flowCommon StockSEC:0000950170-23-052671:0
5,000 shares@ US$131.644.7% of flowCommon StockSEC:0000950170-23-052671:1
3,256 shares@ US$172.964.1% of flowCommon StockSEC:0000950170-23-052671:2
1,744 shares@ US$173.772.2% of flowCommon StockSEC:0000950170-23-052671:3
2,500 shares@ US$5.450.1% of flowCommon StockSEC:0000950170-23-047519:0
2,500 shares@ US$5.450.1% of flowCommon StockSEC:0000950170-23-041288:0
5,000 shares@ US$9.200.3% of flowCommon StockSEC:0000899243-23-011196:0
5,000 shares@ US$5.450.2% of flowCommon StockSEC:0001593968-23-000441:0
5,000 shares@ US$5.450.2% of flowCommon StockSEC:0001593968-23-000303:0
1,527 shares@ US$5.450.1% of flowCommon StockSEC:0001593968-23-000108:0
3,637 shares@ US$7.270.2% of flowCommon StockSEC:0001593968-22-001718:0
5,000 shares@ US$9.200.3% of flowCommon StockSEC:0001593968-22-001591:0
5,000 shares@ US$9.200.4% of flowCommon StockSEC:0001593968-22-001511:0
5,000 shares@ US$7.270.3% of flowCommon StockSEC:0001593968-22-001426:0
5,703 shares@ US$7.270.3% of flowCommon StockSEC:0001593968-22-001336:0
15,000 shares@ US$9.201.0% of flowCommon StockSEC:0001593968-22-001239:0
5,000 shares@ US$9.2020.9% of flowCommon StockSEC:0001593968-22-001097:0
5,000 shares@ US$9.2021.0% of flowCommon StockSEC:0001593968-22-000944:0
25 of 31 declarations
About Brannan Stephen K.
Stephen K. Brannan is the Chief Medical Officer of Karuna Therapeutics, Inc. In this role, he is responsible for the medical direction of the company, overseeing research and development activities related to therapeutic products. His expertise in medicine and biotechnology is essential for guiding clinical initiatives and ensuring that the treatments developed meet the highest standards of safety and efficacy.
